Evidence map›Paper›PMID 26147919›Full record

ArticlePloS one2015

Dose Optimization in TOF-PET/MR Compared to TOF-PET/CT.

Marcelo A Queiroz, Gaspar Delso, Scott Wollenweber, Timothy Deller, Konstantinos Zeimpekis, Martin Huellner, Felipe de Galiza Barbosa, Gustav von Schulthess, Patrick Veit-Haibach

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Reduction of [EJNMMI physics · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Dose Reduction in Brain [Molecular imaging and biology · 2020
    Article
  7. Assessing time-of-flight signal-to-noise ratio gains within the myocardium and subsequent reductions in administered activity in cardiac PET studies.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  8. [Molecular imaging and biology · 2018
    Article
  9. Article
  10. Advances in PET/MR instrumentation and image reconstruction.The British journal of radiology · 2018
    Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marcelo A QueirozDepartment of Medical Imaging, Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Gaspar DelsoGE Healthcare, Waukesha, Wisconsin, United States of America.
Scott WollenweberGE Healthcare, Waukesha, Wisconsin, United States of America.
Timothy DellerGE Healthcare, Waukesha, Wisconsin, United States of America.
Konstantinos ZeimpekisDepartment of Medical Imaging, Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Martin HuellnerDepartment of Medical Imaging, Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland; Department of Medical Imaging, Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
Felipe de Galiza BarbosaDepartment of Medical Imaging, Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Gustav von SchulthessDepartment of Medical Imaging, Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
Patrick Veit-HaibachDepartment of Medical Imaging, Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland; Department of Medical Imaging, Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the possible activity reduction in FDG-imaging in a Time-of-Flight (TOF) PET/MR, based on cross-evaluation of patient-based NECR (noise equivalent count rate) measurements in PET/CT, cross referencing with phantom-based NECR curves as well as initial evaluation of TOF-PET/MR with reduced activity. MATERIALS AND

methodsA total of 75 consecutive patients were evaluated in this study. PET/CT imaging was performed on a PET/CT (time-of-flight (TOF) Discovery D 690 PET/CT). Initial PET/MR imaging was performed on a newly available simultaneous TOF-PET/MR (Signa PET/MR). An optimal NECR for diagnostic purposes was defined in clinical patients (NECRP) in PET/CT. Subsequent optimal activity concentration at the acquisition time ([A]0) and target NECR (NECRT) were obtained. These data were used to predict the theoretical FDG activity requirement of the new TOF-PET/MR system. Twenty-five initial patients were acquired with (retrospectively reconstructed) different imaging times equivalent for different activities on the simultaneous PET/MR for the evaluation of clinically realistic FDG-activities.

resultsThe obtained values for NECRP, [A]0 and NECRT were 114.6 (± 14.2) kcps (Kilocounts per second), 4.0 (± 0.7) kBq/mL and 45 kcps, respectively. Evaluating the NECRT together with the phantom curve of the TOF-PET/MR device, the theoretical optimal activity concentration was found to be approximately 1.3 kBq/mL, which represents 35% of the activity concentration required by the TOF-PET/CT. Initial evaluation on patients in the simultaneous TOF-PET/MR shows clinically realistic activities of 1.8 kBq/mL, which represent 44% of the required activity.

conclusionThe new TOF-PET/MR device requires significantly less activity to generate PET-images with good-to-excellent image quality, due to improvements in detector geometry and detector technologies. The theoretically achievable dose reduction accounts for up to 65% but cannot be fully translated into clinical routine based on the coils within the FOV and MR-sequences applied at the same time. The clinically realistic reduction in activity is slightly more than 50%. Further studies in a larger number of patients are needed to confirm our findings.

Indexed as

Magnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyRadiation DosageTomography, X-Ray ComputedHumans

Identifiers

PMID26147919
PMCPMC4493146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.